Hyperacute renal immunotherapy vaccine
/ Lumos Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 06, 2022
Immunotherapy Study for Metastatic Renal Cell Cancer
(clinicaltrials.gov)
- P1 | N=18 | Completed | Sponsor: NewLink Genetics Corporation | Active, not recruiting ➔ Completed
Trial completion • Clear Cell Renal Cell Carcinoma • Genito-urinary Cancer • Kidney Cancer • Oncology • Renal Cell Carcinoma • Solid Tumor
1 to 1
Of
1
Go to page
1